Before joining Asmacure, Driscoll served as the CEO and director of Javelin Pharmaceuticals, a developer of acute care pain products.
Prior to Javelin, Driscoll held senior positions in Schering-Plough, ViroPharma and Reliant Pharmaceuticals.
Driscoll said he is looking forward to closely working with the Asmacure team as they lead the company through this exciting time of development and growth.